为了获得访问"阿拉丁铁蛋"实时聊天框的流畅支持体验,建议您使用Chrome浏览器或选择360浏览器极速模式(如何切换极速模式?),感谢您选择我们!

阿戈美拉汀, 羟色胺 2c (5-HT2c) 受体拮抗剂

强大的MT 1 / MT 2激动剂和5-HT 2C拮抗剂
规格或纯度: ≥98%(HPLC)
有货

库存信息

关闭

库存信息

关闭

库存信息

关闭

库存信息

关闭

库存信息

关闭

库存信息

关闭

库存信息

关闭
货号 (SKU) 包装规格 是否现货 价格 数量
A124691-5mg
5mg 现货 Stock Image
A124691-25mg
25mg 现货 Stock Image
A124691-50mg
50mg 现货 Stock Image
A124691-250mg
250mg 现货 Stock Image
A124691-1g
1g 现货 Stock Image
A124691-5g
5g 现货 Stock Image
A124691-25g
25g 现货 Stock Image

基本描述

别名 N-[2-(7-甲氧基-1-萘基)乙基]乙酰胺
英文别名 Agomelatine|138112-76-2|Thymanax|Valdoxan|N-(2-(7-Methoxynaphthalen-1-yl)ethyl)acetamide|N-[2-(7-methoxynaphthalen-1-yl)ethyl]acetamide|S20098|S-20098|Agomelatine [INN]|Melitor|AGO-178|S 20098|Acetamide, N-[2-(7-methoxy-1-naphthalenyl)ethyl]-|N-(2-(7-meth
规格或纯度 ≥98%(HPLC)
英文名称 Agomelatine
生化机理 Agomelatine is a competitive antagonist of human and porcine serotonin (5-HT2C) receptors (pKi = 6.2 and 6.4, respectively) as well as human 5-HT2B receptors (pKi = 6.6). It is classified as a norepinephrine-dopamine disinhibitor (NDDI) due to its antagonism of the 5-HT2C receptor. Activation of 5-HT2C receptors by serotonin inhibits dopamine and norepinephrine release. Antagonism of 5-HT2C results in an enhancement of DA and NE release and activity of frontocortical dopaminergic and adrenergic pathways. Agomelatine is also a potent agonist at melatonin receptors which makes it the first melatonergic antidepressant. Agomelatine is an antidepressant drμg.Potent MT 1 /MT 2 agonist (K i values are 0.1 and 0.12 nM, respectively). 5-HT 2C antagonist (IC 50 = 270 nM). Shows antidepressant effects in vivo . Orally active.
储存温度 2-8°C储存
运输条件 冰袋运输
备注 5mg,25mg,50mg售完停产,不再备货。如果有可能,您尽量在使用的当天配置溶液,并在当天使用完它。但是,如果您需要预先配制储备溶液,我们建议您将溶液等份保存在-20°C的密封小瓶中。通常,它们最多可以使用一个月。在使用前和打开样品瓶之前,我们建议您让您的产品在室温下平衡至少1小时。需要更多关于溶解度,用法和处理的建议吗?请访问我们的常见问题(FAQ)页面以获取更多详细信息。
产品介绍

Agomelatine is an extremely potent agonist at both melatonin receptors (MT1 and MT2), with additional antagonism at 5HT2C. It is a novel antidepressant with many desired in vivo properties, including neuroprotection and neurogenesis in depression-sensitive brain areas. Agomelatine′s efficacy appears to be due to both melatonergic and serotonergic properties. In neurogenesis assays, both in vitro and in vivo, the compound effects were differentially affected by antagonists for MT1/MT2 and 5HT2C, demonstrating actions throμgh all three receptors.

Agomelatine is an extremely potent agonist at both melatonin receptors (MT1 and MT2), with additional antagonism at 5HT2C. It is a novel antidepressant with many desired in vivo properties, including neuroprotection and neurogenesis in depression-sensitive brain areas. Agomelatine′s efficacy appears to be due to both melatonergic and serotonergic properties. In neurogenesis assays, both in vitro and in vivo, the compound effects were differentially affected by antagonists for MT1/MT2 and 5HT2C, demonstrating actions through all three receptors.

产品属性

ALogP 2.7

名称和标识符

PubChem SID 488186059
PubChem SID url https://pubchem.ncbi.nlm.nih.gov/substance/488186059
IUPAC Name N-[2-(7-methoxynaphthalen-1-yl)ethyl]acetamide
INCHI InChI=1S/C15H17NO2/c1-11(17)16-9-8-13-5-3-4-12-6-7-14(18-2)10-15(12)13/h3-7,10H,8-9H2,1-2H3,(H,16,17)
InChi Key YJYPHIXNFHFHND-UHFFFAOYSA-N
Canonical SMILES CC(=O)NCCC1=CC=CC2=C1C=C(C=C2)OC
Isomeric SMILES CC(=O)NCCC1=CC=CC2=C1C=C(C=C2)OC
WGK Germany 3
PubChem CID 82148
分子量 243.3

化学和物理性质

溶解性 可溶于甲醇
敏感性 对热敏感
熔点 110 °C

安全和危险性(GHS)

象形图
ghs09

Environmental Hazard

ghs07

Harmful

信号词 Warning
危险声明 H315: Causes skin irritation
H319: Causes serious eye irritation
H335: May cause respiratory irritation
H400: Very toxic to aquatic life
预防措施声明 P261,P305+P351+P338,P273,P280,P302+P352,P321,P405,P501,P264,P271,P304+P340,P403+P233,P362+P364,P391,P264+P265,P337+P317,P332+P317,P319
WGK Germany 3
Merck Index 190

质检证书(COA)

质检报告(COA)

输入批号以搜索COA:

相关文档

质检报告COA

请输入批号:


产品问答

产品问答

登录提交问题 Hover me 请先登录再提交问题
您提交该产品问题后,我们会在1-2个工作日内给您答复,您可以登录"我的账号",然后点击"我的产品问答"查看答案

参考文献

1. Guardiola-Lemaitre B, De Bodinat C, Delagrange P, Millan MJ, Munoz C, Mocaër E.  (2014)  Agomelatine: mechanism of action and pharmacological profile in relation to antidepressant properties..  Br J Pharmacol,  171  (15):  (3604-19).  [PMID:24724693]